# Do GLP-1 Drugs Raise the Risk of Aspiration Pneumonia? | This GLP

Pooled endoscopy data found aspiration in 0.16% of GLP-1 users against 0.12% | after emergency stroke thrombectomy it was 26.8% against 10.3% in 41 users.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia
Updated: 2026-09-18
Published: 2026-09-17

[← Research](https://thisglp.com/research)

Safety

# Do GLP-1 Drugs Raise the Risk of Aspiration Pneumonia?

Not at planned endoscopy, where 210,216 pooled patients showed no significant difference. After emergency stroke treatment, the rate was 26.8% against 10.3%, and the authors say treat anyway.

[This GLP Editorial Team](https://thisglp.com/about)September 20267 min readUpdated September 2026

Aspiration pneumonia within 30 days · on a GLP-1 (n = 41) · 26.8% · not on one (n = 699) · 10.3% · 90-day functional outcome: no difference. · 26.8% of 41 patients is eleven pneumonias.

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).

## Key takeaways

-   At planned endoscopy, no. A pooled analysis of 210,216 patients found aspiration in 0.16% of GLP-1 users and 0.12% of non-users, a difference that was not significant.
-   A BMJ cohort of 43,365 adults with diabetes found 4.15 aspirations per 1,000 on a GLP-1 against 4.26 on an SGLT2 inhibitor.
-   Food left in the stomach is a different finding. The same BMJ cohort found endoscopies stopped about twice as often on a GLP-1.
-   The exception is emergency care. In 41 GLP-1 users having stroke thrombectomy, aspiration pneumonia reached 26.8% against 10.3%.
-   The thrombectomy authors state that the procedure should not be withheld because of GLP-1 use.

At a planned endoscopy, the studies found no increase. A meta-analysis of twelve studies and 210,216 patients found pulmonary aspiration in 0.16% of GLP-1 users and 0.12% of non-users [\[4\]](https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia#ref-4). The odds ratio was 1.23, and it was not statistically significant. Emergency care is the exception. After emergency stroke thrombectomy, aspiration pneumonia occurred in 26.8% of GLP-1 users against 10.3% of non-users [\[1\]](https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia#ref-1).

The reason for the concern is known. These drugs slow gastric emptying. Food can remain in the stomach after a normal fast, as [what to tell the anesthesiologist](https://thisglp.com/research/glp1-before-surgery) sets out. Food left in the stomach is not aspiration. Aspiration means stomach contents reach the lungs. The first is more common on these drugs. The second is what the studies below count.

## Planned endoscopy: no increase found

Three analyses reach the same result. Alkabbani and colleagues compared 43,365 adults with type 2 diabetes in two US insurance databases [\[2\]](https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia#ref-2). Everyone had used a GLP-1 or an SGLT2 inhibitor within 30 days of an upper endoscopy. Aspiration ran 4.15 per 1,000 on a GLP-1 and 4.26 per 1,000 on an SGLT2 inhibitor. The risk ratio was 0.98 (95% CI 0.73 to 1.31).

Velji-Ibrahim and colleagues matched 46,948 patients with diabetes or obesity [\[3\]](https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia#ref-3). Post-endoscopy aspiration pneumonitis had a hazard ratio of 0.92 (95% CI 0.54 to 1.56). Pneumonia had a hazard ratio of 1.01 (0.83 to 1.24). Neither differed between groups.

The meta-analysis adds a warning inside its null result [\[4\]](https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia#ref-4). Its case reports include three patients who aspirated despite stopping the drug more than six days earlier. All three had fasted for over eight hours. The Zepbound label carries a similar warning, covered in [how long Zepbound stays in the body](https://thisglp.com/research/how-long-does-zepbound-stay-in-your-system).

Retained food still stops procedures

The same BMJ cohort found a second result. Endoscopies were stopped 9.79 times per 1,000 on a GLP-1 against 4.91 on an SGLT2 inhibitor. That is a risk ratio of 1.99 (95% CI 1.56 to 2.53). The authors link it to a higher risk of retained gastric content. Whether to hold the drug before a procedure is the clinician’s decision.

## Emergency stroke treatment: a higher rate

A stroke gives no notice. Nobody fasts, and nobody holds the drug. Sardana and colleagues reviewed 740 consecutive patients having thrombectomy at one center [\[1\]](https://thisglp.com/research/do-glp1-drugs-cause-aspiration-pneumonia#ref-1). Of these, 41 were on a GLP-1 at arrival.

The authors state the rule first. Thrombectomy should not be withheld based on GLP-1 exposure alone. Their findings support targeted aspiration-prevention steps instead. An untreated large-vessel stroke is catastrophic. A pneumonia is treatable.

Aspiration pneumonia within 30 days occurred in 26.8% of GLP-1 users and 10.3% of non-users. The absolute difference was 16.5 percentage points. The matched adjusted odds ratio was 3.25 (95% CI 1.43 to 7.40). Twenty-six point eight percent of 41 is eleven pneumonias. Every estimate rests on those eleven events, which is why the interval is wide. The same caution applies to [the overdose comparison](https://thisglp.com/research/overdose-depends-on-the-comparator).

Two outcomes did not differ. Symptomatic brain bleeding occurred in 4.9% against 9.1%, with an odds ratio of 0.32 (95% CI 0.04 to 2.53). Function at 90 days was also similar, with a common odds ratio of 1.14 (0.58 to 2.25). A complication rose. Recovery did not measurably suffer.

## How the two settings fit together

The mechanism is the same in both settings. The circumstances differ. Before a planned procedure, the patient fasts and the team knows the drug is on board. In an emergency, neither is true. The motility evidence is in [the gastroparesis guide](https://thisglp.com/research/do-glp1-drugs-cause-gastroparesis). How other operations fare is in [the surgery outcomes guide](https://thisglp.com/research/does-a-glp1-affect-surgery-outcomes).

## Frequently asked

Do GLP-1 drugs cause aspiration during endoscopy?

The studies found no increase. A meta-analysis of 210,216 patients found aspiration in 0.16% of GLP-1 users against 0.12% of non-users, which was not significant. A cohort of 43,365 adults found 4.15 against 4.26 per 1,000.

Is food left in the stomach the same as aspiration?

It is not. Retained food means the stomach has not emptied. Aspiration means stomach contents reach the lungs. On a GLP-1, endoscopies were stopped about twice as often, likely from retained food, while aspiration did not rise.

Should someone on a GLP-1 avoid emergency stroke treatment?

Do not delay it. The study authors state that thrombectomy should not be withheld on the basis of GLP-1 exposure. Their finding supports aspiration precautions during and after the procedure.

Should I stop my GLP-1 before a procedure?

That decision belongs to the clinician doing the procedure. Tell them you take it and when your last dose was.

## Sources

1.  \[1\] Sardana S, Mateti N, Hackett CT, Singh R, et al. (2026). GLP-1 receptor agonist use and aspiration pneumonia risk following endovascular thrombectomy Journal of NeuroInterventional Surgery. [PMID 42248677](https://pubmed.ncbi.nlm.nih.gov/42248677/)
2.  \[2\] Alkabbani W, Suissa K, Gu KD, Cromer SJ, et al. (2024). Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study BMJ. [PMID 39438043](https://pubmed.ncbi.nlm.nih.gov/39438043/)
3.  \[3\] Velji-Ibrahim J, Nathani P, Patel HK, Sharma P (2025). GLP-1 receptor agonist use does not increase risk of respiratory complications post-endoscopy Endoscopy International Open. [PMID 39958662](https://pubmed.ncbi.nlm.nih.gov/39958662/)
4.  \[4\] Elmati PR, Jagirdhar GSK, Qasba RK, Perez A, et al. (2025). GLP-1 Agonists and the Risk of Pulmonary Aspiration during Elective Upper Endoscopy: A Systematic Review and Meta-analysis The Open Respiratory Medicine Journal. [PMID 41036293](https://pubmed.ncbi.nlm.nih.gov/41036293/)

## More in Safety

-   [
    
    Medication list · Check combinations · Fluid loss · Changes kidney risk · Pharmacist · Choose a safe option
    
    ### Can You Take Ibuprofen With Ozempic? Check Kidney and Stomach Risks
    
    ](https://thisglp.com/research/can-you-take-ibuprofen-with-ozempic)
-   [
    
    1.9% · Placebo · 8.5% · Ozempic 0.5 mg · 8.8% · Ozempic 1 mg
    
    ### Does Ozempic Cause Diarrhea? Rates, Timing, and When to Call
    
    ](https://thisglp.com/research/does-ozempic-cause-diarrhea)
-   [
    
    Sit down · Prevent a fall · Check context · Glucose and fluids · Get help · Severe symptoms
    
    ### Does Ozempic Cause Dizziness? What to Check First
    
    ](https://thisglp.com/research/does-ozempic-cause-dizziness)